European Pharmacopoeia -ph. Eur.- Monograph: Tablets -0478-
The European Pharmacopoeia (Ph. Eur.) Monograph 0478 defines quality standards for oral tablets, covering production, testing, and definitions for various types. It requires strict testing for uniformity of dosage, disintegration, dissolution, and, since Supplement 9.3, specific standards for subdivided (scored) tablet mass. For more details, visit EDQM.
Weaknesses & Gaps (What is missing or problematic)
-
4.1. Appearance
- Visual inspection: homogeneous, free from cracks, chips, or sticking.
- For coated tablets: smooth, uniform coating.
- For sugar-coated tablets: test the mass of the whole tablet (coating + core) using 2.9.5, but note that special acceptance criteria may apply depending on the individual monograph.
- Requires the completion of an A and B identification test. Usually A is chromatographic (e.g., HPLC retention time match) and B is a confirmatory test (e.g., UV spectrum or chemical reaction). This is robust and meets regulatory expectations.
The manufacturing process for tablets involves several steps, including: European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
Gastro-Resistant: Delayed-release tablets intended to resist gastric fluid and release the active substance in the intestinal tract. The European Pharmacopoeia (Ph
If you’d like, I can:
In the pharmaceutical world, the European Pharmacopoeia (Ph. Eur.) is the gold standard for quality control, and Monograph 0478 is the essential blueprint for anyone manufacturing or testing oral tablets. This general monograph defines exactly what a tablet is and sets the baseline requirements for its production and performance. What is Monograph 0478? Visual inspection: homogeneous, free from cracks, chips, or